Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Non-Current Debt (2016 - 2023)

Angiodynamics (ANGO) has disclosed Non-Current Debt for 13 consecutive years, with $49.8 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Non-Current Debt rose 99.27% year-over-year to $49.8 million, compared with a TTM value of $49.8 million through May 2023, up 99.27%, and an annual FY2023 reading of $49.8 million, up 99.27% over the prior year.
  • Non-Current Debt was $49.8 million for Q2 2023 at Angiodynamics, roughly flat from $49.8 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $126.8 million in Q1 2019 and bottomed at $14.3 million in Q1 2020.
  • Average Non-Current Debt over 5 years is $45.9 million, with a median of $40.0 million recorded in 2020.
  • The sharpest move saw Non-Current Debt crashed 88.69% in 2020, then skyrocketed 109.19% in 2021.
  • Year by year, Non-Current Debt stood at $124.4 million in 2019, then plummeted by 67.85% to $40.0 million in 2020, then plummeted by 37.5% to $25.0 million in 2021, then surged by 99.18% to $49.8 million in 2022, then increased by 0.04% to $49.8 million in 2023.
  • Business Quant data shows Non-Current Debt for ANGO at $49.8 million in Q2 2023, $49.8 million in Q1 2023, and $49.8 million in Q4 2022.